Esprinet Earnings Call Transcripts
Fiscal Year 2025
-
FY25 delivered 5% sales growth, strong Iberian performance, and stable EBITDA, with a strategic focus on value-added segments and sustainability. Leadership transitions smoothly to Giovanni Testa, and 2026 guidance will be provided in May.
-
Q3 2025 saw solid growth in revenue, gross profit, and EBITDA, with strong performance in Spain and Portugal offsetting a flat Italian market. Working capital and net debt improved significantly, and the Vammat acquisition is set to boost green tech growth. Guidance for full-year EBITDA adjusted remains at the upper end of EUR 63–71 million.
-
Q2 2025 saw strong 5% revenue growth and a 38% EBITDA increase, offsetting a weak Q1 and driving H1 profitability. Focus remains on high-margin segments, with guidance maintained at EUR 63-71 million EBITDA adjusted, targeting the upper end amid ongoing offering rationalization and macro uncertainties.
-
Q1 2025 delivered strong sales and gross profit growth, led by V-Valley and Zeliatech, but margins were pressured by inflation and higher costs. Guidance for 2025 is cautious, focusing on cost and working capital optimization amid ongoing market unpredictability.
Fiscal Year 2024
-
Strong FY2024 results with 8% EBITDA growth and 6% sales increase, driven by digital, infrastructure, and green tech segments. Outlook for 2025 is positive, with focus on PC refresh, AI, and working capital optimization. Dividend reinstated at €0.40 per share.
-
Q3 2024 delivered strong sales growth and market outperformance, especially in Solutions and Services, despite margin pressure in Devices. Guidance for full-year adjusted EBITDA is EUR 66–71 million, with robust Q4 momentum and positive long-term outlook.
-
Q2 2024 saw a return to growth with 9% higher adjusted EBITDA, improved cash cycle, and market share gains, especially in solutions and services. Outlook remains positive, with guidance maintained and long-term growth expected from digital transformation and AI trends.